Liver Transplantation

Key Points

• Liver transplantation is the definitive treatment for selected patients with end-stage liver disease (ESLD).
• Candidate prioritization is commonly based on MELD scoring, with severity and benefit balancing.
• Contraindications include uncontrolled infection/shock, active high-risk substance use, advanced unrecoverable comorbidity, and major psychosocial barriers.
• Lifelong immunosuppression is required after transplant, with strict adherence to prevent rejection.
• Nursing priorities include early ICU surveillance, infection prevention, medication adherence teaching, and long-term follow-up support.

Pathophysiology

Liver transplantation replaces a failing liver with a donor graft (deceased whole-organ or living-donor partial graft). The transplanted liver can restore synthetic, metabolic, and detoxification function when native liver disease is irreversible.

Without sustained immunosuppression, host immune response can damage or reject the graft. Balancing rejection prevention with infection risk is central to long-term management.

Classification

• Deceased-donor transplant: Whole liver from a deceased donor.
• Living-donor transplant: Partial graft donation; hepatic tissue can regenerate in donor and recipient over time.

Nursing Assessment

NCLEX Focus

In early post-transplant care, trend instability and infection cues aggressively; missed changes can rapidly threaten graft and patient survival.

• Confirm transplant indication and current severity context (often ESLD with MELD-based prioritization).
• Screen for contraindication domains: untreated sepsis/shock, advanced cardiopulmonary disease, active high-risk substance use, metastatic disease, or severe untreated psychosocial instability.
• Monitor immediate postoperative status with high-frequency vitals, intake/output, perfusion, and mental-status trends.
• Assess for rejection and infection cues: fever, graft dysfunction trends, lymph-node or skin changes, and medication nonadherence risks.
• Assess nutrition readiness, mobility progression, pulmonary hygiene capacity, and home-support reliability before discharge.

Nursing Interventions

• Provide intensive early postoperative monitoring with rapid escalation for abnormal hemodynamics, oliguria, bleeding, or respiratory deterioration.
• Reinforce strict immunosuppressant adherence (for example tacrolimus-, mycophenolate-, and glucocorticoid-based regimens per program protocol).
• Teach infection-risk reduction: hand hygiene, crowd-exposure precautions, safe food/water practices, and timely reporting of infectious symptoms.
• Support recovery milestones: incentive spirometry, ambulation progression, pain control, and stepwise nutrition advancement.
• Coordinate interdisciplinary follow-up for medication monitoring, routine cancer screening, and long-term graft surveillance.
• Reinforce alcohol abstinence and relapse-prevention support as part of durable graft protection.

Missed Immunosuppression Doses

Skipped post-transplant immunosuppressant doses can rapidly increase rejection risk; treat adherence lapses as urgent clinical events.

Pharmacology

Drug Class	Examples	Key Nursing Considerations
Calcineurin inhibitors	Tacrolimus	Monitor trough goals, renal effects, neurotoxicity, and interaction risk.
Antimetabolites	Mycophenolate	Monitor cytopenias, GI effects, and infection risk.
Glucocorticoids	Prednisone	Monitor glucose, mood, infection risk, and taper plan adherence.

Clinical Judgment Application

Clinical Scenario

A patient on postoperative day 2 after living-donor liver transplant develops low-grade fever, rising heart rate, and reduced urine output while admitting missed immunosuppressant doses before transfer.

• Recognize Cues: Fever trend, tachycardia, oliguria, and adherence gap.
• Analyze Cues: Early infection or graft-compromise risk with possible rejection contribution.
• Prioritize Hypotheses: Immediate threats are hemodynamic deterioration, infection progression, and graft dysfunction.
• Generate Solutions: Escalate to transplant team, intensify monitoring, obtain ordered labs/cultures, and correct medication schedule.
• Take Action: Initiate prescribed interventions, reinforce strict medication timing, and continue high-frequency reassessment.
• Evaluate Outcomes: Hemodynamics stabilize, infection/graft concerns are clarified, and adherence becomes reliable.

Related Concepts

• liver-failure - Common terminal pathway leading to transplant consideration.
• liver-cirrhosis - Major chronic substrate for transplant candidacy.
• hepatic-encephalopathy - Neurologic decompensation signal in advanced disease.
• ascites - Frequent decompensation feature prompting advanced-intervention planning.